Condition

Primary Polydipsia

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 5 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5

Recruiting1

Common interventions13

Lead sponsors shown2

Clinical trials

5 shown

Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia SyndromeNCT07569861 · 2026-06-16

RECRUITING

Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in ChildrenNCT06604975 · 2025-03-01

NOT_YET_RECRUITING

Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)NCT06542198 · 2024-09-10

COMPLETED

Plasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia SyndromeNCT05890690 · 2023-06-02

COMPLETED

Use of Copeptin in Diabetes InsipidusNCT01940614 · 2013-07-01

COMPLETED

Common interventions

Hypertonic SalineDIAGNOSTIC_TEST1 Hypertonic saline infusionOTHER1 IRMPROCEDURE1 MannitolDIAGNOSTIC_TEST1 Mannitol Infusion (blinded)DIAGNOSTIC_TEST1 Mannitol Infusion (open label)DIAGNOSTIC_TEST1 Measure of arginine-stimulated copeptinPROCEDURE1 Measure of Basal Copeptin levelPROCEDURE1 PlaceboDIAGNOSTIC_TEST1 Placebo Infusion (blinded)DIAGNOSTIC_TEST1 UreaDIAGNOSTIC_TEST1 Water deprivation testOTHER1 Water reduction at homeBEHAVIORAL1

Leading sponsors

University Hospital, Basel, Switzerland 4 Assistance Publique Hopitaux De Marseille 1

Trial status mix

COMPLETED3

NOT_YET_RECRUITING1

RECRUITING1

Phase mix

NA4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.